2021 - Fellow of the Australian Academy of Health and Medical Science
2001 - Fellow of the American Academy of Arts and Sciences
1998 - Charles S. Mott Prize, General Motors Cancer Research Foundation
1997 - Member of the National Academy of Sciences
1992 - Fellow of the Royal Society, United Kingdom
1986 - Fellow of the Australian Academy of Science
Her primary areas of study are Apoptosis, Cell biology, Programmed cell death, Cancer research and Molecular biology. Many of her research projects under Apoptosis are closely connected to Bcl-2-associated X protein and Biphenyl compound with Bcl-2-associated X protein and Biphenyl compound, tying the diverse disciplines of science together. Her Cell biology research is multidisciplinary, relying on both Tissue homeostasis, Protein family, Caspase, Bcl-2 family and Cell cycle.
Her Programmed cell death research is multidisciplinary, incorporating elements of Cell culture, Immunology, Signal transduction, Cytotoxic T cell and Cell type. Her studies deal with areas such as Oncogene, Transgene, Downregulation and upregulation and Lymphoma as well as Cancer research. Her biological study spans a wide range of topics, including RNA, Peptide sequence, Biochemistry, Gene and Lymphocyte.
Suzanne Cory spends much of her time researching Cancer research, Molecular biology, Apoptosis, Cell biology and Transgene. The Cancer research study combines topics in areas such as Progenitor cell, Haematopoiesis, Oncogene and Lymphoma. She has included themes like RNA, Gene, Immunoglobulin heavy chain, Chromosomal translocation and DNA in her Molecular biology study.
Her work deals with themes such as Cell, Cancer and Protein family, which intersect with Apoptosis. Her Cell biology research is multidisciplinary, relying on both Caspase, Tissue homeostasis, Cell cycle and Cell culture. Her Transgene study incorporates themes from Carcinogenesis, Cellular differentiation and Immunology.
Cancer research, Apoptosis, Programmed cell death, Lymphoma and Cell are her primary areas of study. A large part of her Cancer research studies is devoted to Myeloid. Her Apoptosis study combines topics from a wide range of disciplines, such as Genetically modified mouse, Transgene, Cell growth, Immunology and Cytotoxic T cell.
Her Transgene research includes elements of Molecular biology, Haematopoiesis and Lymphocyte. Cell and Cell biology are commonly linked in her work. Her work on Signal transduction as part of general Cell biology study is frequently linked to Phosphatidylserine, therefore connecting diverse disciplines of science.
Suzanne Cory mostly deals with Cancer research, Apoptosis, Lymphoma, Cell biology and Caspase. Her work carried out in the field of Cancer research brings together such families of science as DNA damage, Gene knockdown, Puma, Cell therapy and Tumor suppressor gene. The Apoptosis study combines topics in areas such as Cancer development, Chronic lymphocytic leukemia and Protein family.
Her study on Lymphoma also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Bcl-2 Protein Family: Arbiters of Cell Survival
Jerry M. Adams;Suzanne Cory.
The Bcl2 family: regulators of the cellular life-or-death switch.
Suzanne Cory;Jerry M. Adams.
Nature Reviews Cancer (2002)
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
David L. Vaux;Suzanne Cory;Jerry M. Adams.
The Bcl-2 apoptotic switch in cancer development and therapy
J M Adams;S Cory.
The c- myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
J. M. Adams;A. W. Harris;C. A. Pinkert;L. M. Corcoran.
The Bcl-2 family: roles in cell survival and oncogenesis.
Suzanne Cory;David C S Huang;Jerry M Adams.
Bim: a novel member of the Bcl-2 family that promotes apoptosis
Liam O'Connor;Andreas Strasser;Lorraine A. O'Reilly;George Hausmann.
The EMBO Journal (1998)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
Mark F. van Delft;Andrew H. Wei;Kylie D. Mason;Kylie D. Mason;Cassandra J. Vandenberg.
Cancer Cell (2006)
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Andreas Strasser;Alan W. Harris;Suzanne Cory.
Life-or-death decisions by the Bcl-2 protein family
Jerry M Adams;Suzanne Cory.
Trends in Biochemical Sciences (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: